Amyris announced that it has entered into a definitive purchase agreement for the purchase and sale of 20M shares of the company’s common stock and warrants to purchase up to an aggregate of 15,000,000 shares of common stock in a registered direct offering. Each share of common stock is being sold together with a warrant to purchase 0.75 of a share of common stock at a combined purchase price of $1.50. The warrants will be immediately exercisable at a price of $1.80 per full share of common stock for a period of five years from closing. H.C. Wainwright & Co. is acting as the exclusive placement agent for the registered direct offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AMRS:
- Amyris advances transaction for rights to supply two of its ingredients
- Largest borrow rate increases among liquid names
- Amyris downgraded to Underweight after ‘disappointing’ Q3 at JPMorgan
- Amyris downgraded to Underweight from Neutral at JPMorgan
- Amyris downgraded to Perform from Outperform at Oppenheimer